Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Pregnancy, puerperium and perinatal conditions – page 2

  • 93 clinical trials
  • 52 recruiting
  • 63 conditions
  • 25 countries

Conditions in this area

63 conditions with trials, the busiest first

Central nervous system lymphoma10Bronchopulmonary dysplasia9Pre-eclampsia8Cerebral palsy5Retinopathy of prematurity5Foetal growth restriction4Infantile apnoea4Neonatal respiratory distress syndrome4Netherton's syndrome4Neonatal alloimmune thrombocytopenia3Perineal injury3Premature baby3Abortion threatened2Diffuse large B-cell lymphoma2Gestational diabetes2Habitual abortion2Hypoxic ischaemic encephalopathy neonatal2Induced labour2Neonatal respiratory failure2Noonan syndrome2Perinatal depression2Placenta praevia2Pregnancy2Premature rupture of membranes2+39

Clinical trials in Pregnancy, puerperium and perinatal conditions

93 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

93 clinical trials

Preterm premature rupture of membranes

Recruiting

Study on Betamethasone Sodium Phosphate and Drug Combination for Pregnant Women with Preterm Premature Rupture of Membranes

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Ampicillin Sodium
  • Sponsor:Vseobecna Fakultni Nemocnice V Praze

Central nervous system lymphoma+1

Recruiting

Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:LYSARC

Premature baby+3

Recruiting

Study on the Effect of Caffeine Citrate for Patients with Extubation Failure and Bronchopulmonary Dysplasia

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Caffeine Citrate
  • Sponsor:Semmelweis University

Preterm premature rupture of membranes

Recruiting

Study of oxytocin, dinoprostone, and misoprostol combination for active management in pregnant women with premature rupture of membranes

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Dinoprostone
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena

Pregnancy

Recruiting

Study on Antibiotic Levels in Blood of Pregnant Women with Twins Using Piperacillin, Tazobactam, Cefazolin, Ampicillin Sodium, and Clindamycin

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Ampicillin Sodium
  • Sponsor:Medical University Of Vienna

Induced labour

Recruiting

Comparison of Oxytocin versus Prostaglandins (Dinoprostone and Misoprostol) for Labor Induction in Women with Unfavorable Cervix After Initial Cervical Ripening

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Dinoprostone
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Neonatal alloimmune thrombocytopenia

Recruiting

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Perineal injury

Recruiting

Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Lidocaine
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

Habitual abortion

Recruiting

Study on Hydroxychloroquine for Women with Recurrent Pregnancy Loss

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Hydroxychloroquine Sulfate
  • Sponsor:Hvidovre Hospital

Premature rupture of membranes

Recruiting

Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Nifedipine
  • Sponsor:Assistance Publique Hopitaux De Paris

Neonatal respiratory distress syndrome

Recruiting

Study comparing prophylactic versus selective surfactant (poractant alfa, phospholipid fraction) administration in preterm infants with respiratory distress syndrome aged 25-30 weeks

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Poractant Alfa
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Labour pain

Recruiting

Study of oxycodone safety and effectiveness for pain relief during labor and its effects on newborns

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Oxycodone Hydrochloride Trihydrate
  • Sponsor:Pohjois-Savon hyvinvointialue

Substances studied in this area

The therapies tested most often in Pregnancy, puerperium and perinatal conditions trials.

Rituximab7 clinical trialsAcetylsalicylic Acid5 clinical trialsMethotrexate4 clinical trialsMisoprostol4 clinical trialsAmoxicillin3 clinical trialsDinoprostone3 clinical trialsMetformin Hydrochloride3 clinical trialsMifepristone3 clinical trialsNipocalimab3 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.